Navigation Links
New Flu Vaccine Can Give Lifetime Protection

A new innovative vaccine for flu is under pre-clinical phase of trail and make soon be available and provide lifetime protection against flu. //

Flu is caused by virus and the present vaccine protects against three strains of the virus. . Flu is an extremely contagious condition and makes one feel really ill. In addition, flu can have extremely serious consequences: According to the World Health Organization, on average 10 to 20% of the world's population is infected by flu every year. This leads to 3 to 5 million hospitalizations and 250 000 to 500 000 deaths a year.

The current vaccine is not produced by the growth of viruses, but the active component is produced in bacteria. Therefore the production process will be more effective, safer and cheaper.

This week the Flanders University Institute for Biotechnology (VIB) has entered into an agreement with the British company Acambis for the development of a new flu vaccine.

Together VIB and Acambis want to develop a universal flu vaccine that offers protection from all flu variants. Furthermore this vaccine will not need to be renewed annually. VIB researchers linked to the Ghent University - led by Walter Fiers, professor Molecular Biology and former director of one of the Ghent VIB departments - carried out the research on which this new flu vaccine is basedVIB and the British company Acambis are collaborating on the development of a universal flu vaccine that offers protection to all flu variants. Walter Fiers, co-inventor ( UGent and VIB ) said:

'The structure of M2e is almost identical in all known flu viruses that can be transmitted between people. We indicated that the M2e vaccine offers full protection to flu without side effects in mice. This way vaccination against all human flu viruses is possible, not only against viruses returning yearly, but even against future epidemics. Through our cooperation with Acambis we can continue the developme nt of this promising vaccine.'

Vaccination offers the most efficient protection to flu. The present flu vaccines are a mixture of three vaccines, each offering protection to a certain virus strain. Vaccination reduces death and the amount of hospitalizations as a result of flu considerably. The government strongly advises flu vaccination for those over 60 years old, diabetes patients, people with diminished resistance or chronic kidney, heart and lung disorders. However, everyone can consider vaccination: it will give you 80% less chance of getting the flu next winter.

For further information contact: Karine Clauwaert karine.clauwaert@vib.be 32-9-244-6611 VIB, Flanders Interuniversity Institute of Biotechnology (News Source: http://i-newswire.com/pr40686.html)

Medindia on Influenza Virus: Cold is an illness that is short in duration, usually less than two weeks, does not usually produce fever, except in children. It is most prevalent among children, and seem to be related to youngsters' relative lack of resistance to infection and to contacts with other children in schools. The common cold causes irritation and drainage in any or all of the airways including the nose, sinuses, throat, voice box, and often the bronchial tubes.

More on Medindia:

http://www.medindia.net/patients/
PatientInfo/commoncold_about.htm

'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 top five ... art competition. Selected from 15 submissions from around the nation, the top five finalists ... iaedp Symposium, March 22 – 26 in Las Vegas. , This year, the competition ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle ... hosted their Military Wedding Giveaway, with the winning couple announced on Feb. 14, ... services generously donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... Mass. (PRWEB) , ... February 23, 2017 , ... ... as an approved content provider for the National Institute for Health and ... and social care-related organizations in the National Health Service (NHS) to search, order ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... announced today that it will soon begin franchising throughout the U.S. starting this ... to help bring the practice of meditation mainstream. Current Meditation will be the ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... BRISBANE, Australia , Feb. 23, 2017  Directors from Pharma ... the two companies have joined forces, resulting in the founding of ... . Pharma To Market are pleased to announce their ... an office in Singapore . The company are ... Consulting as Co-Director of the Singapore based ...
(Date:2/24/2017)... Feb 24, 2017 Medivir AB ... for a new Board of Directors that will be ... Nomination Committee comprises representatives of the company,s three largest ... 2016 who have accepted a seat on the Nomination ... of the 2016-2017 Nomination Committee was as follows:  ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Autism ... to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis and ... global Autism Spectrum Disorder market. The research answers the following ... marketed for Autism Spectrum Disorder and their clinical attributes? How are ...
Breaking Medicine Technology: